122
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Dynamics of Health Technology Diffusion in the Integrated Care System (DHTDICS): A Development and Validation Study in China

, , , ORCID Icon &
Pages 331-344 | Published online: 27 Jan 2021

References

  • Gröne O, Garcia-Barbero M; WHO European Office for Integrated Health Care Services. Integrated care: a position paper of the WHO European Office for Integrated Health Care Services. Int J Integr Care. 2001;1:e21. doi:10.5334/ijic.28
  • Nooteboom L, Mulder E, Kuiper C, Vermeiren R. Towards integrated care in the Dutch Youth Care system: an action based research. Int J Integr Care. 2019;19:1–2. doi:10.5334/ijic.s3152
  • Kodner DL. Beyond care management: the logic and promise of vertically integrated systems of care for the frail elderly. In: Knapp M, Challis D, Fernández J, Netten A, editors. Long-Term Care: Matching Resources and Needs. London: Routledge; 2018:101–117.
  • Filliettaz SS, Berchtold P, Kohler D, Peytremann BI. Integrated care in Switzerland: results from the first nationwide survey. Health Policy (New York). 2018;122:568–576. doi:10.1016/j.healthpol.2018.03.006
  • Xu J, Pan R, Pong RW, Miao Y, Qian D. Different models of hospital–community health centre collaboration in selected cities in China: a cross-sectional comparative study. Int J Integr Care. 2016;16:8. doi:10.5334/ijic.2456
  • Sun BX, Zhang RH, Chen Y, He SC. [Development and challenges of current medical consortium in China]. Med Philos. 2015;36:45–46. Chinese.
  • Liang J, Zheng X, Chen Z, et al. The experience and challenges of healthcare-reform-driven medical consortia and Regional Health Information Technologies in China: a longitudinal study. Int J Med Inform. 2019;131:103954. doi:10.1016/j.ijmedinf.2019.103954
  • Song H, Zuo X, Cui C, Meng K. The willingness of patients to make the first visit to primary care institutions and its influencing factors in Beijing medical alliances: a comparative study of Beijing’s medical resource-rich and scarce regions. BMC Health Serv Res. 2019;19:361. doi:10.1186/s12913-019-4184-0
  • Integrated care for older people: realigning primary health care to respond to population ageing [homepage on the Internet]. Geneva: World Health Organization; 2018. Available from: https://apps.who.int/iris/handle/10665/326295. Accessed October 1, 2020.
  • Kao WY, Chao Y, Chang CC, et al. Prognosis of early-stage hepatocellular carcinoma: the clinical implications of substages of Barcelona Clinic Liver Cancer System based on a cohort of 1265 patients. Medicine. 2015;94:e1929. doi:10.1097/MD.0000000000001929
  • Ji J, Wang H, Li Y, et al. Diagnostic evaluation of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatitis B virus-related hepatocellular carcinoma in China: a large-scale, multicentre study. PLoS One. 2016;11:e0153227. doi:10.1371/journal.pone.0153227
  • Sultanik P, Ginguay A, Vandame J, et al. Diagnostic accuracy of des‐gamma‐carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse® G600 analyzer. J Viral Hepat. 2017;24:80–85. doi:10.1111/jvh.12622
  • Li Y, Chen J. Serum Des-gamma-carboxy prothrombin for diagnosis of adult primary cancer in liver. J Coll Physicians Surg Pak. 2019;29:972–976. doi:10.29271/jcpsp.2019.10.972
  • Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10573–10583. doi:10.3748/wjg.v21.i37.10573
  • Song P, Feng X, Inagaki Y, et al. Japan-China Joint Team for Medical Research and Cooperation on HCC. Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: a multi-center case-controlled study of 1,153 subjects. Biosci Trends. 2014;8:266–273. doi:10.5582/bst.2014.01116
  • Tateishi R, Uchino K, Fujiwara N, et al. A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update. J Gastroenterol. 2019;54:367–376. doi:10.1007/s00535-018-1532-5
  • Que Z. The clinical value of combined detection of GGT, AFU, DCP and AFP in diagnosis of hepatocarcinoma. Chin J Prim Med Pharm. 2015;5:743–745.
  • Song P, Feng X, Zhang K, et al. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China. Biosci Trends. 2013;7:1–6.
  • BenYishay A, Jones M, Kondylis F, Mushfiq AM. Gender gaps in technology diffusion. J Dev Econ. 2020;143:102380. doi:10.1016/j.jdeveco.2019.102380
  • Willis J. Technology diffusion in the “soft disciplines”: using social technology to support information technology. Comput Schools. 1992;1:81–106. doi:10.1300/J025v09n01_07
  • Agha L, Molitor D. The local influence of pioneer investigators on technology adoption: evidence from new cancer drugs. Rev Econ Stat. 2018;1:29–44. doi:10.1162/REST_a_00670
  • Rogers EM. Diffusion of Innovations. New York: Simon and Schuster; 2010.
  • Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–211. doi:10.1016/0749-5978(91)90020-T
  • Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q. 1989;13:319–340. doi:10.2307/249008
  • Rogers EM. Diffusion of Innovations. New York: Simon and Schuster; 1995.
  • Tornatzky LG, Fleischer M. Processes of Technological Innovation. David AT, ed. Massachusetts: Lexington books; 1990.
  • Ross J, Stevenson F, Lau R, Murray E. Factors that influence the implementation of e-health: a systematic review of systematic reviews (an update). Implement Sci. 2016;11:146. doi:10.1186/s13012-016-0510-7
  • Weir NM, Newham R, Dunlop E, Bennie M. Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research. Implement Sci. 2019;14(1):21. doi:10.1186/s13012-019-0867-5
  • Felgner S, Ex P, Henschke C. Physicians’ decision making on adoption of new technologies and role of coverage with evidence development: a qualitative study. Value Health. 2018;21:1069–1076. doi:10.1016/j.jval.2018.03.006
  • Balas EA, Chapman WW. Road map for diffusion of innovation in health care. Health Aff. 2018;37:198–204. doi:10.1377/hlthaff.2017.1155
  • Paré G, Sicotte C, Poba-Nzaou P, Balouzakis G. Clinicians’ perceptions of organizational readiness for change in the context of clinical information system projects: insights from two cross-sectional surveys. Implement Sci. 2011;6:15. doi:10.1186/1748-5908-6-15
  • Wilcock M, Harding G. What do pharmacists think of MURs and do they change prescribed medication? Pharm J. 2008;281:163–167.
  • Kummer TF, Recker J, Bick M. Technology-induced anxiety: manifestations, cultural influences, and its effect on the adoption of sensor-based technology in German and Australian hospitals. Inform Manage. 2017;54:73–89. doi:10.1016/j.im.2016.04.002
  • Blank JLT, Valdmanis VG. Technology diffusion in hospitals: a log odds random effects regression model. Int J Health Plann Manage. 2015;30:246–259. doi:10.1002/hpm.2232
  • Kim KK, Sankar P, Wilson MD, Haynes SC. Factors affecting willingness to share electronic health data among California consumers. BMC Med Ethics. 2017;18:25. doi:10.1186/s12910-017-0185-x
  • Weitzman ER, Kelemen S, Kaci L, Mandl KD. Willingness to share personal health record data for care improvement and public health: a survey of experienced personal health record users. BMC Med Inform Decis Mak. 2012;12:39. doi:10.1186/1472-6947-12-39
  • Wang BB, Wan TTH, Burke DE, Bazzoli GJ, Lin BYJ. Factors influencing health information system adoption in American hospitals. Health Care Manage Rev. 2005;30:44–51. doi:10.1097/00004010-200501000-00007
  • Liu CF. Key factors influencing the intention of telecare adoption: an institutional perspective. Telemed J E Health. 2011;17:288–293. doi:10.1089/tmj.2010.0184
  • Benavides VS, Strode A, Sheeran BC. Using technology in the delivery of mental health and substance abuse treatment in rural communities: a review. J Behav Health Serv Res. 2013;40:111–120. doi:10.1007/s11414-012-9299-6
  • Sun KX, Zheng RS, Zhang SW, et al. Report of cancer incidence and mortality in different areas of China, 2015]. China Cancer. 2019;28(01):4–14. Chinese.
  • Zhou Y, Ma JY, Jiang HJ, Lin YT. [Analysis of cancer incidence and mortality in Fujian cancer registries, 2014]. Chin J Clin Oncol. 2018;45(17):898–903. Chinese.
  • Liu J, Zhu LP, Yang XL, Xu Y, Yan W, Chen YY. [Incidence, mortality and life lost of malignancies among residents living in areas covered by cancer registry in Jiangxi province, 2010–2017]. Chin J Public Health. 2018;34(12):1692–1695. Chinese.
  • Nunnally JC. Psychometric Theory. 2nd ed. New York: McGraw-Hill; 1978.
  • Ahmad MH, Ibrahim MI, Rahman AA, et al. Development and validation of positive smoker identity questionnaire (PSmoQi): a new instrument for smoking cessation correlates. Int J Environ Res Public Health. 2019;16:351. doi:10.3390/ijerph16030351
  • Gefen D, Straub DW, Boudreau MC. Structural equation modeling and regression: guidelines for research practice. Commun Assoc Inf Syst. 1978;4:1–70.
  • Gorusch RL. Factor Analysis. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1983.
  • Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and measurement error. J Mark Res. 1981;18:39–50. doi:10.1177/002224378101800104
  • Bagozzi RP, Yi Y. On the evaluation of structure equation models. J Acad Mark Sci. 1998;16:74–94. doi:10.1007/BF02723327
  • Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39:31–36. doi:10.1007/BF02291575
  • Ramli R, Ali N, Teleconsultation as knowledge management system: recognizing the issues contributing to its underutilization in hospitals. Proceedings of the 2018 International Conference on Advanced Computer Science and Information Systems (ICACSIS); 2018 Oct 27–28; Yogyakarta, Indonesia, New York: IEEE.
  • Coughlin JM, Zang Y, Terranella S, et al. Understanding barriers to lung cancer screening in primary care. J Thorac Dis. 2020;12(5):2536–2544. doi:10.21037/jtd.2020.03.66
  • Dulai GS, Farmer MM, Ganz PA, et al. Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting. Cancer. 2010;100(9):1843–1852. doi:10.1002/cncr.20209
  • Hudson PS, Ana LDV. Health technology diffusion in developing countries: a case study of CT scanners in Brazil. Health Policy Plann. 2018;26(5):385–394.
  • Wani D, Malhotra M. Does the meaningful use of electronic health records improve patient outcomes? J Oper Manage. 2018;60:1–18. doi:10.1016/j.jom.2018.06.003
  • Elnahal SM, Peabody H, Ippolito A, Littlefield P, Clancy C, Shulkin D. Diffusing oncology care model best practices across America’s largest integrated hospital system. Int J Radiat Oncol. 2016;96:E397–E398. doi:10.1016/j.ijrobp.2016.06.1630
  • Saini V, Brownlee S, Elshaug AG, Glasziou P, Heath I. Addressing overuse and underuse around the world. Lancet. 2017;390(10090):105–107. doi:10.1016/S0140-6736(16)32573-9
  • Weiner BJ. A theory of organizational readiness for change. Implement Sci. 2009;4:67. doi:10.1186/1748-5908-4-67
  • Eby LT, Adams DM, Russell JEA, Gabe SH. Perceptions of organizational readiness for change: factors related to employees’ reactions to the implementation of team-based selling. Hum Relat. 2000;53:419–442. doi:10.1177/0018726700533006
  • Holt DT, Helfrich CD, Hall CG, Weiner BJ. Are you ready? How health professionals can comprehensively conceptualize readiness for change. J Gen Intern Med. 2010;25:50–55. doi:10.1007/s11606-009-1112-8
  • Liu C, Liu C, Wang D, Zhang X. Intrinsic and external determinants of antibiotic prescribing: a multi-level path analysis of primary care prescriptions in Hubei, China. Antimicrob Resist Infect Control. 2019;8:132. doi:10.1186/s13756-019-0592-5
  • Young HP. The evolution of social norms. Ann Rev Econ. 2015;7:359–387. doi:10.1146/annurev-economics-080614-115322